2009•Practical Journal of Cardiac Cerebral Pneumal and Vascular DiseaseRequires access

The Protective Effects of Telmisartan and Benazepri on Patients with Diabetic Nephropathy

Xiumin Zhang

Abstract

Objective To study the effects of telmisartan and benazepri on patients with diabetic nephropathy(DN),so as to provide the rationality of clinical medication.Methods In this study 80 patients with DN were randomly divided into three groups:group A received telmisartan,group B telmisartan combine benazepri for 3 months.Scr,HbA1c and Total urinary albumin excretion serumwere observe.Results There were significant differences(P0.05) among these two groups protein after treatment.There are lower levels of Scr,HbA1c and total urinary albumin in combine group than the other group.Conclusion Losartan combined with captopril was more effective and rational in treating patients with early DN without side effec.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Telmisartan, Medicine, Losartan, Captopril, Diabetic nephropathy, Urology, Nephropathy, Internal medicine